NCT02650856View on ClinicalTrials.gov

Blood Loss Reduction After Total Knee Arthroplasty. Comparison Topical Tranexamic Acid vs Platelet Rich Plasma

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 9, 2017

Study Completion Date

March 9, 2017

Conditions
Osteoarthritis
Interventions
DRUG

Group 1 Tranexamic Acid

2 gr of tranexamic acid will be applied on the surgical site.

BIOLOGICAL

Group 2 Platelet rich plasma

16ml of platelet rich plasma will be applied of the surgical site

Trial Locations (1)

1-4469

Facultad de Medicina UANL, Monterrey

All Listed Sponsors
lead

Universidad Autonoma de Nuevo Leon

OTHER

NCT02650856 - Blood Loss Reduction After Total Knee Arthroplasty. Comparison Topical Tranexamic Acid vs Platelet Rich Plasma | Biotech Hunter | Biotech Hunter